Capital Research Global Investors 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 2:14 pm Sale |
2024-12-31 | 13G | Denali Therapeutics Inc. DNLI |
Capital Research Global Investors | 5,477,211 3.800% |
-2,431,903 (-30.75%) |
Filing |
| 2024-11-12 12:52 pm Purchase |
2024-11-07 | 13G | Denali Therapeutics Inc. DNLI |
Capital Research Global Investors | 7,909,114 5.500% |
7,909,114 (New Position) |
Filing |